02/28/2025
7:00 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
4:20 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
JB CAPITAL PARTNERS LP (Filed by)
| Form SCHEDULE 13G/A | |
01/22/2025
8:50 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
GEYGAN JAMES (Reporting)
GEYGAN JEFFREY RICHART (Reporting)
Geygan Kathleen (Reporting)
GLOBAL VALUE INVESTMENT CORP. (Reporting)
Rice Shawn G (Reporting)
Wilke Stacy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:02 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
GLOBAL VALUE INVESTMENT CORP. (Filed by)
| Form SCHEDULE 13D/A | |
01/17/2025
1:05 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
3:16 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
1:58 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
11:10 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4/A | |
12/06/2024
11:11 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
12/06/2024
11:12 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4/A | |
12/06/2024
11:13 AM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4/A | |
Get the Latest News and Ratings for COGT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cogent Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
12/04/2024
1:33 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
1:35 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
1:37 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
1:43 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:49 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
GEYGAN JAMES (Reporting)
GEYGAN JEFFREY RICHART (Reporting)
Geygan Kathleen (Reporting)
GLOBAL VALUE INVESTMENT CORP. (Reporting)
Rice Shawn G (Reporting)
Wilke Stacy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/03/2024
4:15 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
GLOBAL VALUE INVESTMENT CORP. (Filed by)
| Form SC 13D/A | |
12/02/2024
5:40 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 424B5 | |
12/02/2024
5:03 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:32 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form NT 10-Q | |
11/15/2024
3:30 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/11/2024
4:36 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
1:26 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
11:15 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form EFFECT | |
08/27/2024
8:00 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/26/2024
4:18 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
| Form SC 13D/A | |
08/23/2024
3:35 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
| Form SC 13D/A | |
08/23/2024
3:36 PM | Conlin Matthew (Filed by)
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
| Form SC 13D/A | |
08/21/2024
1:24 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
10:59 AM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
11:01 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
11:03 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
11:04 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
11:20 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 10-Q/A | |
08/19/2024
4:13 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024
3:27 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
4:01 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form NT 10-Q | |
07/22/2024
3:52 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
| Form SC 13D/A | |
07/17/2024
5:20 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:00 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
11:40 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
🚨This Week: The Political Fallout from Nvidia’s AI Conference (Ad) Something big is happening TWO days from now on March 20th — and the political world isn’t ready for it.
Nvidia is poised to unveil a groundbreaking AI breakthrough, and the implications could shake Washington, Wall Street, and Main Street alike.
While the media focuses on tariff chaos and global conflicts, no one is paying attention to the AI revolution that could shift economic power overnight THIS THURSDAY. Click here now to see how this tech shift could redefine America’s future — and your financial desti |
07/08/2024
2:49 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
2:51 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
11:15 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
9:06 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
SHATTUCK KOHN BARBARA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
9:10 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Mathis Donald H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
9:13 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Graff David Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
9:15 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
PFENNIGER RICHARD C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
7:53 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:54 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:55 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:56 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:57 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:45 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
06/18/2024
3:43 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
11:14 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form DEFA14A | |
06/07/2024
10:35 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
4:27 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form DEF 14A | |
05/30/2024
3:45 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/23/2024
4:19 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form PRE 14A | |
05/20/2024
4:28 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
| Form SC 13D/A | |
05/16/2024
7:02 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
11:21 AM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
| Form SC 13D/A | |
05/16/2024
11:22 AM | Conlin Matthew (Filed by)
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
| Form SC 13D/A | |
05/15/2024
8:55 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:30 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
3:50 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024
3:18 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
4:22 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
4:21 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form ARS | |
04/02/2024
3:21 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
4:18 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
5:01 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
4:57 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
